news_6

Investigation Report on China’s Osimertinib Market 2021-2025: A Small Molecule Targeted Anti-tumor Drug Used to Treat Non-small Cell Lung Cancer (NSCLC) – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Investigation Report on China's Osimertinib Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Osimertinib is a small...

news_6

Investigation Report on China’s Osimertinib Market 2021-2025: A Small Molecule Targeted Anti-tumor Drug Used to Treat Non-small Cell Lung Cancer (NSCLC) – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Investigation Report on China's Osimertinib Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Osimertinib is a small...

news_6

Lyra Therapeutics and LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets

Partnership opens expanded opportunity for LYR-210 to address chronic rhinosinusitis, a disease affecting approximately 88 million adults in China WATERTOWN,...

news_6

Lyra Therapeutics and LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets

Partnership opens expanded opportunity for LYR-210 to address chronic rhinosinusitis, a disease affecting approximately 88 million adults in China WATERTOWN,...